Multistage selection strategies: Simulating the effects on adverse impact and expected performance for various predictor combinations.

David M. Finch; Bryan D. Edwards; J. Craig Wallace

doi:10.1037/a0013775

Multistage selection strategies: Simulating the effects on adverse impact and expected performance for various predictor combinations.

Journal of Applied Psychology ◽

10.1037/a0013775 ◽

2009 ◽

Vol 94 (2) ◽

pp. 318-340 ◽

Cited By ~ 18

Author(s):

David M. Finch ◽

Bryan D. Edwards ◽

J. Craig Wallace

Keyword(s):

Adverse Impact ◽

Selection Strategies ◽

Expected Performance ◽

Multistage Selection

Download Full-text

Predicting adverse impact and mean criterion performance in multistage selection.

Journal of Applied Psychology ◽

10.1037/0021-9010.91.3.523 ◽

2006 ◽

Vol 91 (3) ◽

pp. 523-537 ◽

Cited By ~ 28

Author(s):

Wilfried De Corte ◽

Filip Lievens ◽

Paul R. Sackett

Keyword(s):

Adverse Impact ◽

Multistage Selection

Download Full-text

SSAIS: a Program to Assess Adverse Impact in Multistage Selection Decisions

Educational and Psychological Measurement ◽

10.1177/0013164404264119 ◽

2004 ◽

Vol 64 (4) ◽

pp. 640-646

Author(s):

Wilfried De Corte

Keyword(s):

Adverse Impact ◽

Selection Decisions ◽

Multistage Selection

Download Full-text

The miR-21 potential of serving as a biomarker for liver diseases in clinical practice

Biochemical Society Transactions ◽

10.1042/bst20200653 ◽

2020 ◽

Vol 48 (5) ◽

pp. 2295-2305

Author(s):

Jiawei Zhang ◽

Dandan Li ◽

Rui Zhang ◽

Peng Gao ◽

Rongxue Peng ◽

...

Keyword(s):

Clinical Practice ◽

Liver Diseases ◽

Hepatic Disease ◽

Noninvasive Detection ◽

Diagnosis And Prognosis ◽

Expected Performance ◽

Potential Biomarker ◽

Disease Condition ◽

Complex Regulatory Network

The role of miR-21 in the pathogenesis of various liver diseases, together with the possibility of detecting microRNA in the circulation, makes miR-21 a potential biomarker for noninvasive detection. In this review, we summarize the potential utility of extracellular miR-21 in the clinical management of hepatic disease patients and compared it with the current clinical practice. MiR-21 shows screening and prognostic value for liver cancer. In liver cirrhosis, miR-21 may serve as a biomarker for the differentiating diagnosis and prognosis. MiR-21 is also a potential biomarker for the severity of hepatitis. We elucidate the disease condition under which miR-21 testing can reach the expected performance. Though miR-21 is a key regulator of liver diseases, microRNAs coordinate with each other in the complex regulatory network. As a result, the performance of miR-21 is better when combined with other microRNAs or classical biomarkers under certain clinical circumstances.

Download Full-text

Is Retest Bias Biased?

Journal of Personnel Psychology ◽

10.1027/1866-5888/a000149 ◽

2016 ◽

Vol 15 (2) ◽

pp. 45-54 ◽

Cited By ~ 4

Author(s):

Jason G. Randall ◽

Anton J. Villado ◽

Christina U. Zimmer

Keyword(s):

Sex Differences ◽

Emotional Stability ◽

Adverse Impact ◽

Mental Ability ◽

Ability Test ◽

General Mental Ability ◽

Psychological Mechanisms

Abstract. The purpose of this study was to test for race and sex differences in general mental ability (GMA) retest performance and to identify the psychological mechanisms underlying these differences. An initial and retest administration of a GMA assessment separated by a six-week span was completed by 318 participants. Contrary to our predictions, we found that race, sex, and emotional stability failed to moderate GMA retest performance. However, GMA assessed via another ability test and conscientiousness both partially explained retest performance. Additionally, we found that retesting may reduce adverse impact ratios by lowering the hiring threshold. Ultimately, our findings reinforce the need for organizations to consider race, sex, ability, and personality when implementing retesting procedures.

Download Full-text